Moderna, Pfizer, Johnson & Johnson: How Are Covid Vaccine Stocks Doing?

Our indicative theme of Coronavirus Vaccine stocks - which includes a diverse set of U.S. based pharma and biotech stocks that are working on Covid-19 vaccines - is up by about 730% year-to-date, on an equally weighted basis, compared to the S&P 500 which has gained just about 4% over the same...